Pricing
  1. JP-listed companies
  2. Linical Co., Ltd.
  3. Financials
  4. Net income margin (%)

Linical Co., Ltd.【JP:2183】

Market cap
¥6.9B
P/E ratio
-3.7x
Linical helps pharmaceutical companies develop and launch new drugs by providing clinical trial services, post-market safety monitoring, and drug discovery support.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 2025-5.2-287.94%
Mar 31, 20242.7-65.75%
Mar 31, 20238+17.29%
Mar 31, 20226.8+30.23%
Mar 31, 20215.3+18.93%
Mar 31, 20204.4-12.10%
Mar 31, 20195-64.67%
Mar 31, 201814.2-17.91%
Mar 31, 201717.3-0.21%
Mar 31, 201617.4+93.48%
Mar 31, 20159-25.22%
Mar 31, 201412-30.30%
Mar 31, 201317.2+23.04%
Mar 31, 201214

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)